ARCHIVES

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

TTF Increased Survival Compared To Chemotherapy

December 31, 2010